Plant ID: NPO3392
Plant Latin Name: Agastache rugosus
Taxonomy Genus: Agastache
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
CDK2; | |
ALDH1A1; | |
TP53; | |
ABCG2; | |
SMN1;SMN2; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | CDK2 | Cyclin-dependent kinase 2 | P24941 | CHEMBL301 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0031571; mitotic G1 DNA damage checkpoint | 8.667E-06 | 6.917E-02 | CDK2, TP53 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.271E-05 | 6.917E-02 | CYP2A6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0016712; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.236E-05 | 2.716E-01 | CYP2A6, CYP3A4 |
BP | GO:0009987; cellular process | GO:0006977; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.597E-04 | 3.950E-01 | CDK2, TP53 |
CC | GO:0043226; organelle | GO:0016604; nuclear body | 3.575E-03 | 6.754E-01 | CDK2, LMNA, TP53 |
CC | GO:0032991; macromolecular complex | GO:0043235; receptor complex | 9.230E-03 | 9.950E-01 | ABCG2, TSHR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.714E-06 | 1.574E-04 | CYP2A6, ALDH1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.844E-04 | 4.451E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.157E-04 | 4.451E-03 | CYP2A6, CYP3A4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04115 | p53 signaling pathway | 4.157E-04 | 4.451E-03 | CDK2, TP53 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.653E-04 | 4.451E-03 | CYP2A6, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 6.907E-04 | 4.451E-03 | CDK2, TP53 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.402E-04 | 4.451E-03 | CYP3A4, ABCG2 |
09160 Human Diseases | 09161 Cancers | hsa05222 | Small cell lung cancer | 6.452E-04 | 4.451E-03 | CDK2, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.867E-04 | 4.451E-03 | CYP2A6, CYP3A4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.696E-03 | 8.197E-03 | LMNA, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 1.602E-03 | 8.197E-03 | CDK2, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 1.842E-03 | 8.220E-03 | CDK2, TP53 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04110 | Cell cycle | 1.334E-03 | 7.738E-03 | CDK2, TP53 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.248E-03 | 9.314E-03 | CYP2A6 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
C00-D49: Neoplasms | Cancer | C00-C96 | TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |